, Volume 40, Issue 6, pp 685–687 | Cite as

Pet animals and foreign travel are risk factors for colonisation with extended-spectrum β-lactamase-producing Escherichia coli

  • E. MeyerEmail author
  • P. Gastmeier
  • A. Kola
  • F. Schwab
Brief Report



The purpose of this study was to determine the prevalence of extended-spectrum β-lactamase (ESBL) and vancomycin-resistant enterococci (VRE) colonisation among healthy infection control personnel and to determine risk factors for ESBL or VRE colonisation within this group.


Participants were recruited at an infection control symposium in 2011. Volunteers were asked to perform a rectal swab and to fill in questionnaires on risk factors of ESBL or VRE carriage (report on diet, contact with domestic or production animals, travel, hospital stay and antibiotic use all within the last 12 months). Rectal swabs were inoculated onto ESBL and VRE chromogenic agar; species identification and susceptibility testing was done by using a VITEK 2 system. In the multivariable analysis, a logistic regression with stepwise forward variable selection was performed.


Two hundred and thirty people participated in the study, i.e. 36 % of the symposium attendees (231/639). No VRE faecium or faecalis were isolated, whereas ESBL were isolated from 8 out of 231 individuals, i.e. 3.5 % (95 % confidence interval 1.5–6.7). In the multivariable analysis, travel to Greece or Africa and contact with pets were independently associated with ESBL positivity. The odds ratios were as follows: travel to Greece 15.2, travel to Africa 14.8 and for having a pet animal 6.7.


This is the first report showing that contact with pets increases by almost seven-fold the chance to be colonised with ESBL Escherichia coli. A colonisation rate of 3.5 % with ESBL-producing enterobacteriaceae among infection control personnel is of concern and reflects probably less an occupational health risk but the reservoir of and the expansion into the community, especially in persons with pet animals and travel history to high-endemicity countries.


Rectal Swab Antibiotic Consumption Determine Risk Factor National Nosocomial Infection Surveillance National Nosocomial Infection Surveillance System 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Conflict of interest



  1. 1.
    Pfeifer Y, Cullik A, Witte W. Resistance to cephalosporins and carbapenems in Gram-negative bacterial pathogens. Int J Med Microbiol. 2010;300:371–9.PubMedCrossRefGoogle Scholar
  2. 2.
    Knothe H, Shah P, Krcmery V, Antal M, Mitsuhashi S. Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens. Infection. 1983;11:315–7.PubMedCrossRefGoogle Scholar
  3. 3.
    Livermore DM, Canton R, Gniadkowski M, Nordmann P, Rossolini GM, Arlet G, et al. CTX-M: changing the face of ESBLs in Europe. J Antimicrob Chemother. 2007;59:165–74.PubMedCrossRefGoogle Scholar
  4. 4.
    Rodríguez-Baño J, López-Cerero L, Navarro MD, Díaz de Alba P, Pascual A. Faecal carriage of extended-spectrum beta-lactamase-producing Escherichia coli: prevalence, risk factors and molecular epidemiology. J Antimicrob Chemother. 2008;62:1142–9.PubMedCrossRefGoogle Scholar
  5. 5.
    Wieler LH, Ewers C, Guenther S, Walther B, Lübke-Becker A. Methicillin-resistant staphylococci (MRS) and extended-spectrum beta-lactamases (ESBL)-producing Enterobacteriaceae in companion animals: nosocomial infections as one reason for the rising prevalence of these potential zoonotic pathogens in clinical samples. Int J Med Microbiol. 2011;301:635–41.PubMedCrossRefGoogle Scholar
  6. 6.
    Laupland KB, Church DL, Vidakovich J, Mucenski M, Pitout JD. Community-onset extended-spectrum beta-lactamase (ESBL) producing Escherichia coli: importance of international travel. J Infect. 2008;57:441–8.PubMedCrossRefGoogle Scholar
  7. 7.
    Tängdén T, Cars O, Melhus A, Löwdin E. Foreign travel is a major risk factor for colonization with Escherichia coli producing CTX-M-type extended-spectrum beta-lactamases: a prospective study with Swedish volunteers. Antimicrob Agents Chemother. 2010;54:3564–8.PubMedCrossRefGoogle Scholar
  8. 8.
    Strömdahl H, Tham J, Melander E, Walder M, Edquist PJ, Odenholt I. Prevalence of faecal ESBL carriage in the community and in a hospital setting in a county of Southern Sweden. Eur J Clin Microbiol Infect Dis. 2011;30:1159–62.PubMedCrossRefGoogle Scholar
  9. 9.
    Vinué L, Sáenz Y, Martínez S, Somalo S, Moreno MA, Torres C, et al. Prevalence and diversity of extended-spectrum beta-lactamases in faecal Escherichia coli isolates from healthy humans in Spain. Clin Microbiol Infect. 2009;15:954–7.PubMedCrossRefGoogle Scholar
  10. 10.
    Sasaki Y, Tsujiyama Y, Kusukawa M, Murakami M, Katayama S, Yamada Y. Prevalence and characterization of Shiga toxin-producing Escherichia coli O157 and O26 in beef farms. Vet Microbiol. 2011;150:140–5.PubMedCrossRefGoogle Scholar
  11. 11.
    Ko YJ, Moon HW, Hur M, Park CM, Cho SE, Yun YM. Fecal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae in Korean community and hospital settings. Infection. 2012. Epub 2012/06/23.Google Scholar
  12. 12.
    Sankar S, Narayanan H, Kuppanan S, Nandagopal B. Frequency of extended-spectrum beta-lactamase (ESBL)-producing Gram-negative bacilli in a 200-bed multi-specialty hospital in Vellore district, Tamil Nadu, India. Infection. 2012. 40:425–9.PubMedCrossRefGoogle Scholar
  13. 13.
    Meyer E, Conrad A, Schneider C, Serr A, Babikir R, Dettenkofer M. Burden of imported cases of infection or colonization with multidrug-resistant organisms in a German university hospital. Infect Control Hosp Epidemiol. 2008;29:1195–6.PubMedCrossRefGoogle Scholar
  14. 14.
    Meyer E, Ziegler R, Mattner F, Schwab F, Gastmeier P, Martin M. Increase of patients co-colonised or co-infected with methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus faecium or extended-spectrum beta-lactamase-producing Enterobacteriaceae. Infection. 2011;39:501–6.PubMedCrossRefGoogle Scholar
  15. 15.
    Baran J Jr, Ramanathan J, Riederer KM, Khatib R. Stool colonization with vancomycin-resistant enterococci in healthcare workers and their households. Infect Control Hosp Epidemiol. 2002;23:23–6.PubMedCrossRefGoogle Scholar
  16. 16.
    van den Braak N, Kreft D, van Belkum A, Verbrugh H, Endtz H. Vancomycin-resistant enterococci in vegetarians. Lancet. 1997;350:146–7.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2012

Authors and Affiliations

  • E. Meyer
    • 1
    • 2
    Email author
  • P. Gastmeier
    • 1
    • 2
  • A. Kola
    • 1
    • 2
  • F. Schwab
    • 1
    • 2
  1. 1.Institute of Hygiene and Environmental MedicineCharité University Medicine BerlinBerlinGermany
  2. 2.National Reference Centre for Surveillance of Nosocomial InfectionsBerlinGermany

Personalised recommendations